Physician and patient influences on provider performance: β-blockers in postmyocardial infarction management in the MI-Plus study.
نویسندگان
چکیده
BACKGROUND Efforts to improve the quality of care for patients with cardiovascular disease frequently target the decrease of physician-level performance variability. We assessed how variability in providing β-blockers to ambulatory postmyocardial infarction (MI) patients was influenced by physician and patient level characteristics. METHODS AND RESULTS β-Blocker prescription and patient characteristics were abstracted from charts of post-MI patients treated by 133 primary care physicians between 2003 and 2007 and linked to physician and practice characteristics. Associations of β-blocker prescription with physician- and patient-level characteristics were examined using mixed-effects models, with physician-level effects as random. Mean physician-specific predicted probabilities and the intraclass correlations, which assessed the proportion of variance explainable at the physician level, were estimated. Of 1901 patients without major contraindication, 69.1% (range across physicians, 20% to 100%) were prescribed β-blockers. Prescription varied with comorbidity from 78.3% in patients with chronic kidney disease to 54.7% for patients with stroke. Although physician characteristics such as older physician age, group practice, and rural location were each positively associated with β-blocker prescription, physician factors accounted for only 5% to 8% of the variance in β-blocker prescription; the preponderance of the variance, 92% to 95%, was at the patient level. The mean physician-specific probability of β-blocker prescription (95% confidence interval) in the fully adjusted model was 63% (61% to 65%). CONCLUSIONS β-Blocker prescription rates were surprisingly low. The contribution of physician factors to overall variability in β-blocker prescription, however, was limited. Increasing evidence-based use of β-blockers may not be accomplished by focusing mostly on differential performance across physicians.
منابع مشابه
Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004.
PURPOSE Myocardial infarction (MI) survivors benefit from receiving secondary prevention, including beta-blockers, angiotensin-blocking agents, and statins, as recommended by guidelines. Compliance with these guidelines is suboptimal. We sought to describe the initiation of secondary prevention in MI survivors, and to describe the variation in initiation by discharging the hospital, the physici...
متن کاملThe Effect of Upper Limb Exercise on the Readmission Rate of Myocardial Infarction Patients
Background Myocardial infarction (MI) is among the most frequent causes of mortality and morbidity, with socioeconomic harms. Upper limb exercise, as part of cardiac rehabilitation program, is one of the secondary prevention methods of further MI and disease improvement. Objective The present study investigated the effect of upper limb sport on the rate of readmission in patients with myocard...
متن کاملارتباط پلیمرفیسم T13254C گلیکوپروتئین VI پلاکتی با سکته حاد قلبی زودرس
Background and Aim: Myocardial infarction (MI) is a major cause of morbidity and mortality worldwide. Epidemiological studies indicate that MI results from complex interactions between long-term environmental influences, concomitant disorders, and genetic susceptibility factors. Identification of genetic risk factors, particularly in premature MI, is very important. Since thrombosis plays a cri...
متن کاملA two-year survey on the effect of temperature changes on the incidence of myocardial infarction in patients referred to the Ali-ibn Abi Talib Hospital, Rafsanjan, Iran, in 2013-2014
Background: The role of temperature changes, as an environmental risk factor, in the human health status has been investigated in recent studies. Accordingly, the present two-year study was conducted to evaluate the incidence of myocardial infarction (MI) in warm and cold seasons in Ali-ibn Abi Talib Hospital, Rafsanjan, Iran. Materials and Methods: In this descriptive and cross-sectional st...
متن کاملEffects of ACE inhibition and β-receptor blockade on energy metabolism in rats postmyocardial infarction.
Chronic treatment with β-receptor blockers or angiotensin-converting enzyme (ACE) inhibitors in heart failure can reduce mortality and improve left ventricular function, but the mechanisms involved in their beneficial action remain to be fully defined. Our hypothesis was that these agents prevent the derangement of cardiac energy metabolism. Rats were subjected to myocardial infarction (MI) or ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Circulation. Cardiovascular quality and outcomes
دوره 4 1 شماره
صفحات -
تاریخ انتشار 2011